California Public Employees Retirement System’s BridgeBio Pharma BBIO Stock Holding History

California Public Employees Retirement System’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.8M	Buy	253,479 +45,596	+22%	+$3.3M	0.01%	646
2025 Q4	$15.9M	Sell	207,883 -44,878	-18%	-$2.95M	0.01%	715
2025 Q3	$13.1M	Buy	+252,761	New	+$12.3M	0.01%	804
2022 Q1	–	Sell	-179,629	Closed	-$3M	–	1229
2021 Q4	$3M	Sell	179,629 -37,231	-17%	-$1.58M	﹤0.01%	1202
2021 Q3	$10.2M	Buy	216,860 +1,104	+0.5%	+$59.2K	0.01%	991
2021 Q2	$13.2M	Sell	215,756 -7,543	-3%	-$431K	0.01%	885
2021 Q1	$13.8M	Buy	223,299 +43,146	+24%	+$2.82M	0.01%	873
2020 Q4	$12.8M	Buy	180,153 +14,816	+9%	+$715K	0.01%	869
2020 Q3	$6.2M	Buy	165,337 +4,200	+3%	+$132K	0.01%	1101
2020 Q2	$5.25M	Buy	161,137 +113,909	+241%	+$3.47M	0.01%	1167
2020 Q1	$1.37M	Buy	47,228 +9,713	+26%	+$301K	﹤0.01%	1815
2019 Q4	$1.31M	Buy	+37,515	New	+$1.04M	﹤0.01%	2235

Other funds holding BBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System's BBIO Position: Q1 2026 in Review

California Public Employees Retirement System increased its BridgeBio Pharma (BBIO) stake by 22% in Q1 2026, buying an estimated $3.3M and bringing the position to 253,479 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #646.

California Public Employees Retirement System first reported a position in BBIO in Q4 2019 and has held it in 12 quarters since. 458 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

California Public Employees Retirement System held 253,479 shares of BridgeBio Pharma worth $18.8M as of Q1 2026.
California Public Employees Retirement System bought 45,596 BridgeBio Pharma shares in Q1 2026, an estimated $3.3M.
BridgeBio Pharma made up 0.01% of California Public Employees Retirement System's portfolio in Q1 2026, its #646 holding.
California Public Employees Retirement System first reported a position in BridgeBio Pharma in Q4 2019 and has held it in 12 quarters since.
458 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on California Public Employees Retirement System's 13F filing for Q1 2026, filed 6 May 2026.